Evidence map›Paper›PMID 42131205›Full record

ArticleFrontiers in microbiology2026

Genomic characterization of

Melese Hailu Legese, Daniel Asrat, Dejenie Shiferaw Teklu, Ashenafi Alemu Wami, Badrul Hasan, Adane Mihret, Abraham Aseffa, Göte Swedberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Melese Hailu LegeseDepartment of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Daniel AsratDepartment of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Dejenie Shiferaw TekluEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Ashenafi Alemu WamiArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Badrul HasanDepartment of Medical Biochemistry and Microbiology, Biomedical Centre, Uppsala University, Uppsala, Sweden.
Adane MihretArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Abraham AseffaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Göte SwedbergDepartment of Medical Biochemistry and Microbiology, Biomedical Centre, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Treating sepsis caused by high-priority Methods: A multicenter study was conducted from October 2019 to September 2020 at four hospitals across Ethiopia's central, southern, and northern regions. Blood cultures from 1,416 patients suspected of sepsis were processed, and isolates were identified using MALDI-TOF. Whole-genome sequencing (WGS) was performed on an Illumina HiSeq 2500, and various bioinformatics tools were used for genome analysis and visualization. Results: A total of 97 Conclusion:

Indexed as

carbapenemase genesEthiopiaextended-spectrum beta-lactamase (ESBL)Klebsiella pneumoniaesepsiswhole genome sequencing

Identifiers

PMID42131205
PMCPMC13161078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.